NOV 26, 2018 3:10 PM PST

New Insight Into the Machinery That Drives Cell Death

WRITTEN BY: Carmen Leitch

When cells are worn out and damaged or diseased, they can initiate a self-destruct sequence called apoptosis. Now researchers at the Walter and Eliza Hall Institute (WEHI) have learned more about the molecular machinery that drives apoptosis. When unwanted cells are programmed to die, the team found that a protein called VDAC2 is essential to Bax, a pro-apoptosis protein. The findings, which also showed that VDAC2 helps certain therapeutics to kill cancer, have been published in Nature Communications.

Apoptosis is animated in the video above from WEHI.

Our cells have to be able to kill themselves off when necessary, and apoptosis is an essential process in the proper development and maintenance of our bodies. Dysfunction in apoptotic machinery has been linked to the development of many disorders including heart, neurodegenerative, autoimmune and infectious diseases as well as cancer.

"Bax helps to take a cell to a 'point of no return' when apoptotic cell death is triggered, forming pores in mitochondria, the powerhouses of the cell. This unleashes the final 'executioner' proteins that dismantle a cell,” said study co-author Dr. Mark van Delft of the University of Melbourne.

"Understanding how Bax functions could lead to new therapeutics that either promote cell death - with applications for diseases such as cancer - or therapeutics that prevent cell death, which have the potential to save cells in conditions such as neurodegenerative disorders or stroke," he said.

The team wanted to know more about how Bax and Bak, another related protein, work to kill cells. They used CRISPR to test the function of various genes, explained co-author Grant Dewson, WEHI associate professor.

"To our surprise, we discovered a gene that was essential for the function of Bax but not Bak, despite these two proteins being functionally and structurally very similar. We were able to follow up on this research to show that the protein, called VDAC2, was a catalyst that helped Bax associate with mitochondria and form pores in their membranes, to kill the cell," Dewson said. "Intriguingly VDAC2's 'day job' is to maintain the function of the mitochondria, pumping metabolites in and out of the mitochondria."

Huang noted that in cancer cells, the cell death machinery tends to fail, which has also been linked to cancer cells that are resistant to therapeutics. 

"Bax is important for helping anti-cancer agents kill cells - without Bax and its relative Bak, cancer cells cannot undergo apoptosis when treated with a range of anti-cancer therapies. Our research showed that VDAC2 is required for Bax to drive the response of cancer cells to conventional chemotherapy agents as well as the recently developed BH3-mimetics," added Huang.


Sources: AAAS/Eurekalert! Via Walter and Eliza Hall Institute, Nature Communications

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 30, 2022
Coronavirus
A New Kind of Antiviral Against SARS-CoV-2
SEP 30, 2022
A New Kind of Antiviral Against SARS-CoV-2
Scientists are developing a human version of a drug that was highly beneficial to a hamster model of COVID-19. The drug, ...
OCT 25, 2022
Cell & Molecular Biology
Liver Disease Discovery Resolves Controversy
OCT 25, 2022
Liver Disease Discovery Resolves Controversy
Liver diseases are a serious health problem. Chronic liver disease is estimated to impact over 1.5 billion people.
OCT 31, 2022
Genetics & Genomics
Ancient Viral DNA in Our Genome Has a Protective Function
OCT 31, 2022
Ancient Viral DNA in Our Genome Has a Protective Function
There is viral DNA in the human genome, and each instance traces back to an ancestor who was infected with a retrovirus. ...
NOV 04, 2022
Health & Medicine
Cannabis Users and Liver Transplants
NOV 04, 2022
Cannabis Users and Liver Transplants
Are cannabis consumers eligible for liver transplants? Here's the details
NOV 28, 2022
Drug Discovery & Development
Experimental Drug Lowers 'Bad' Cholesterol by 70%
NOV 28, 2022
Experimental Drug Lowers 'Bad' Cholesterol by 70%
An experimental orally-administered drug reduces 'bad cholesterol' in mice by 70%. The corresponding research wa ...
NOV 30, 2022
Immunology
Rogue, Cancer-Linked Immune Cells Found to Drive Autoimmune Disorders
NOV 30, 2022
Rogue, Cancer-Linked Immune Cells Found to Drive Autoimmune Disorders
Leukemia patients are more likely to get autoimmune disorders like aplastic anemia or rheumatoid arthritis than unaffect ...
Loading Comments...